Loss from operations      (54,747)      (94,423)     (230,546)     (316,952) 
 
 Change in fair 
  value of 
  derivative tranche 
  liability                     -             -             -        10,291 
 Interest income            7,535        10,502        25,132        20,486 
 Other income 
  (expense), net           (1,336)          (19)       36,221          (254) 
Net loss              $   (48,548)  $   (83,940)  $  (169,193)  $  (286,429) 
                       ----------    ----------    ----------    ---------- 
Other comprehensive 
gain (loss) 
 Unrealized gain 
  (loss) on 
  short-term 
  marketable 
  securities, net             551           (94)          222            36 
  Total other 
   comprehensive 
   gain (loss)        $       551   $       (94)  $       222   $        36 
                       ----------    ----------    ----------    ---------- 
Net loss and other 
 comprehensive loss   $   (47,997)  $   (84,034)  $  (168,971)  $  (286,393) 
                       ==========    ==========    ==========    ========== 
Net loss per share 
 attributable to 
 common 
 stockholders, basic 
 and diluted          $     (0.49)  $     (0.87)  $     (1.71)  $     (4.68) 
Weighted-average 
 common shares 
 outstanding, basic 
 and diluted           99,835,707    96,872,747    98,973,518    61,138,105 
                       ==========    ==========    ==========    ========== 
 
 
                             ACELYRIN, INC. 
                Selected Consolidated Balance Sheet Data 
                              (unaudited) 
                             (in thousands) 
 
                           September 30,              December 31, 
                      ------------------------  ------------------------ 
                                2024                      2023 
                          ----------------          ---------------- 
 Cash and cash 
  equivalents          $           216,326       $           218,097 
 Short-term 
  marketable 
  securities                       346,047                   503,229 
 Total assets                      618,310                   742,690 
 Total liabilities                  90,029                    86,353 
 Accumulated deficit              (657,912)                 (488,719) 
 

ACELYRIN Contacts:

Tyler Marciniak

Vice President of Investor Relations and Corporate Affairs

investors@acelyrin.com

media@acelyrin.com

(END) Dow Jones Newswires

November 13, 2024 16:00 ET (21:00 GMT)